Correlation Between Body Mass Index and Clinical Outcomes in Advanced Renal Cell Carcinoma Patients
A higher ORR for the combination of ipilimumab and nivolumab was observed in patients with high BMI compared to those with low BMI. IMDC poor risk and the presence of liver metastasis significantly influenced the prognosis of patients with advanced RCC treated with the combination.
Authors
- Yozo Mitsui (ORCID: https://orcid.org/0000-0003-2919-0058)
- Shotaro Nishimura (ORCID: https://orcid.org/0000-0001-9347-6451)
- Tatsushi Kawada (ORCID: https://orcid.org/0000-0002-8369-9712)
- Satoshi Katayama (ORCID: https://orcid.org/0000-0002-8377-2457)
- Takehiro Iwata (ORCID: https://orcid.org/0000-0001-6116-543X)
- Tomoko Kobayashi
- Kohei Edamura
- Seiya Inoue (ORCID: https://orcid.org/0000-0003-0945-0000)
- Takuya Sadahira
- Tomoaki Yamanoi (ORCID: https://orcid.org/0009-0006-9821-9407)
- Motoo Araki (ORCID: https://orcid.org/0000-0002-3172-2482)
- Yusuke Tominaga
- Kensuke Bekku (ORCID: https://orcid.org/0000-0003-0002-1592)
- K. Yoshinaga
Institutions
- Okayama University (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-05-27
- DOI
- https://doi.org/10.21873/anticanres.17635
- Citations
- 1
- Primary Topic
- Multiple and Secondary Primary Cancers
- Type
- article
- Field-Weighted Citation Impact
- 1.35